Sjögren Syndrome without Focal Lymphocytic Infiltration of the Salivary Glands.
Antibodies, Antinuclear
/ blood
Autoantibodies
/ blood
Autoantigens
/ immunology
Biopsy
Cell Movement
/ immunology
Gene Expression Regulation
Histological Techniques
Humans
Interferons
/ genetics
Keratoconjunctivitis Sicca
/ blood
Lymphocytes
/ immunology
RNA, Small Cytoplasmic
/ immunology
Rheumatoid Factor
/ blood
Ribonucleoproteins
/ immunology
Salivary Glands
/ immunology
Sjogren's Syndrome
/ blood
SS-B Antigen
AUTOANTIBODIES
INTERFERON
PRIMARY SJÖGREN SYNDROME
Journal
The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
accepted:
01
05
2019
pubmed:
17
5
2019
medline:
21
5
2021
entrez:
17
5
2019
Statut:
ppublish
Résumé
Primary Sjögren syndrome (SS) is characterized by a focal lymphocytic infiltrate in exocrine glands. We describe patients who lacked this key feature. We evaluated patients with sicca in a comprehensive clinic at which medical, dental, and ophthalmological examinations were performed. All subjects underwent a minor salivary gland biopsy with focus score calculation. Extraglandular manifestations were also determined. We categorized subjects as high, intermediate, or low in terms of expression of interferon (IFN)-regulated genes. About 20% (51 of 229, 22%) of those classified as having primary SS had a focus score of zero. Compared to those with anti-Ro positivity and a focus score > 1.0, the patients with focus score of zero (who by classification criteria must be anti-Ro-positive) were statistically less likely to have anti-La (or SSB) and elevated immunoglobulin, as well as less severe corneal staining. The focus score zero patients were less likely to have elevated expression of IFN-regulated genes in peripheral blood mononuclear cells than anti-Ro-positive SS patients with a focal salivary infiltrate. There are only a few clinical differences between patients with primary SS with focus score zero and those with both anti-Ro and a focus score > 1.0. The small subset of focus score zero patients tested did not have elevated expression of IFN-regulated genes, but did have systemic disease. Thus, extraglandular manifestations are perhaps more related to the presence of anti-Ro than increased IFN. This may have relevance to pathogenesis of SS.
Identifiants
pubmed: 31092717
pii: jrheum.181443
doi: 10.3899/jrheum.181443
pmc: PMC7304293
mid: NIHMS1528481
doi:
Substances chimiques
Antibodies, Antinuclear
0
Autoantibodies
0
Autoantigens
0
RNA, Small Cytoplasmic
0
RO60 protein, human
0
Ribonucleoproteins
0
Interferons
9008-11-1
Rheumatoid Factor
9009-79-4
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
394-399Subventions
Organisme : NIGMS NIH HHS
ID : U54 GM104938
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI082714
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR053483
Pays : United States
Organisme : NIAMS NIH HHS
ID : P50 AR060804
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR073750
Pays : United States
Organisme : BLRD VA
ID : I01 BX001451
Pays : United States
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Références
J Oral Pathol Med. 2001 Aug;30(7):408-12
pubmed: 11488418
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
RMD Open. 2015 Feb 20;1(1):e000022
pubmed: 26509054
Clin Exp Rheumatol. 2017 May-Jun;35(3):438-444
pubmed: 28229827
Arch Ophthalmol. 1969 Jul;82(1):10-4
pubmed: 4183019
Am J Ophthalmol. 2010 Mar;149(3):405-15
pubmed: 20035924
Ann Rheum Dis. 2017 Jul;76(7):1161-1168
pubmed: 27965259
PLoS Genet. 2017 Jun 22;13(6):e1006820
pubmed: 28640813
Arthritis Rheum. 2011 Jul;63(7):2014-20
pubmed: 21337320
Clin Rheumatol. 2007 Jul;26(7):1099-103
pubmed: 17522950
Lancet. 2005 Jul 23-29;366(9482):321-31
pubmed: 16039337
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
Bioinformatics. 2004 Jun 12;20(9):1453-4
pubmed: 14871861
Ann Rheum Dis. 2014 Aug;73(8):1537-40
pubmed: 24525912
Respir Med. 2018 Apr;137:95-102
pubmed: 29605220
Arthritis Rheumatol. 2017 Nov;69(11):2187-2192
pubmed: 28692793
Bioinformatics. 2004 Nov 22;20(17):3246-8
pubmed: 15180930
Clin Immunol. 2016 Jul;168:25-29
pubmed: 27109640
Ann Rheum Dis. 2008 Jul;67(7):949-54
pubmed: 17962240
Lupus. 2015 Mar;24(3):315-20
pubmed: 25297554
Arthritis Rheum. 1984 Feb;27(2):147-56
pubmed: 6696772
Arthritis Rheumatol. 2014 Dec;66(12):3445-56
pubmed: 25199908
J Autoimmun. 2012 Aug;39(1-2):43-8
pubmed: 22297146
Ann Rheum Dis. 2017 Jan;76(1):9-16
pubmed: 27789466
Front Immunol. 2013 Sep 20;4:290
pubmed: 24062752
Genes Immun. 2009 Jun;10(4):285-96
pubmed: 19404300
Rheumatology (Oxford). 1999 Mar;38(3):245-53
pubmed: 10325663
Arthritis Rheum. 1998 Dec;41(12):2238-48
pubmed: 9870881
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Arthritis Rheum. 2008 Jan;58(1):15-25
pubmed: 18163481
Ann Rheum Dis. 2014 Jan;73(1):31-8
pubmed: 23968620
J Oral Pathol Med. 2001 Jan;30(1):1-6
pubmed: 11140894
Ann Rheum Dis. 2010 Jun;69(6):1103-9
pubmed: 19561361